In vitro M-like cells genesis through a tissue-engineered triple-culture intestinal model

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 104, Issue 4, 2016, Pages 782-788

  Araújo, Francisca ^a,b,c   Pereira, Carla ^a,b,c   Costa, Joana ^a,b,c   Barrias, Cristina ^a,b   Granja, Pedro L ^a,b,c   Sarmento, Bruno ^a,b,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

Author keywords

Caco 2 cells; follicle associated epithelium; HT29 MTX cells; M like cells; tissue engineered in vitro model

Indexed keywords

ANTIGENS; BODY FLUIDS; CYTOLOGY; TISSUE; TISSUE ENGINEERING;

CACO-2 CELLS; DRUG PERMEABILITIES; FOLLICLE-ASSOCIATED EPITHELIUM; IN-VITRO MODELS; MICROENVIRONMENTS; ORAL DRUG DELIVERY; TRADITIONAL MODELS; TRANS DIFFERENTIATIONS;

CELLS;

HUMAN INSULIN; METHOTREXATE;

CACO 2 CELL LINE; CELL TRANSDIFFERENTIATION; CELLS BY BODY ANATOMY; COCULTURE; CONFERENCE PAPER; DRUG PENETRATION; EPITHELIUM CELL; HT 29 CELL LINE; IN VITRO STUDY; MICROFOLD CELL; MICROVILLUS; MUCUS; RAJI CELL LINE; TISSUE ENGINEERING; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CACO-2 CELL LINE; CYTOLOGY; HUMAN; INTESTINE MUCOSA; METABOLISM;

ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CACO-2 CELLS; HUMANS; INTESTINAL MUCOSA; TISSUE ENGINEERING;

EID: 84940689050     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33508     Document Type: Conference Paper

References (44)

1. Russell M,. Mucosal Immunity in New Bacterial Vaccines. Springer; 2003. 63-79.
2. Hathaway LJ, Kraehenbuhl JP., The role of M cells in mucosal immunity. Cell Mol Life Sci 2000; 57: 323-332.
3. Clark AM, Jepson MA, Hirst BH., Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 2001; 50: 81-106.
4. Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A., Microfold (M) cells: Important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol 2013; 6: 666-677.
5. Gebert A, Pabst R., M cells at locations outside the gut. Semin Immunol 1999; 11: 165-170.
6. Nicoletti C., Unsolved mysteries of intestinal M cells. Gut 2000; 47: 735-739.
7. Gebert A, Rothkötter H-J, Pabst R., M Cells in Peyer's Patches of the Intestine. In:, Kwang WJ, editor. Int Rev Cytol: Academic Press; 1996. pp 91-159.
8. Torche AM, Jouan H, Le Corre P, Albina E, Primault R, Jestin A, Le Verge R., Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment. Int J Pharm 2000; 201: 15-27.
9. Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR., Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. J Control Release 1990; 11: 205-214.
10. Jones BD, Ghori N, Falkow S., Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994; 180: 15-23.
11. Westphal S, Lügering A, von Wedel J, von Eiff C, Maaser C, Spahn T, Heusipp G, Schmidt A, Herbst H, Williams I, Domschke W, Kucharzik T,. Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: Evidence of defective M-cell formation in vivo. Am J Pathol 2008; 172: 671-680.
12. Ponnusamy D, Periasamy S, Tripathi BN, Pal A., Mycobacterium avium subsp. paratuberculosis invades through M cells and enterocytes across ileal and jejunal mucosa of lambs. Res Vet Sci 2013; 94: 306-312.
13. Morin MJ, Warner A, Fields BN., A pathway for entry of reoviruses into the host through M cells of the respiratory tract. J Exp Med 1994; 180: 1523-1527.
14. Foster N, Clark MA, Jepson MA, Hirst BH., Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 1998; 16: 536-541.
15. Manocha M, Pal PC, Chitralekha KT, Thomas BE, Tripathi V, Gupta SD, Paranjape R, Kulkarni S, Rao DN., Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. Vaccine 2005; 23: 5599-5617.
16. Helander A, Silvey KJ, Mantis NJ, Hutchings AB, Chandran K, Lucas WT, Nibert ML, Neutra MR., The viral σ1 protein and glycoconjugates containing α2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol 2003; 77: 7964-7977.
17. Clark MA, Hirst BH, Jepson MA., M-cell surface β1 integrin expression and invasin-mediated targeting of yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun 1998; 66: 1237-1243.
18. Bhalla DK, Owen RL., Cell renewal and migration in lymphoid follicles of Peyer's patches and cecum-an autoradiographic study in mice. Gastroenterology 1982; 82: 232-242.
19. Smith MW, Peacock MA., "M" cell distribution in follicle-associated epithelium of mouse Peyer's patch. Am J Anat 1980; 159: 167-175.
20. Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E., Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997; 277: 949-952.
21. Araújo F, Sarmento B., Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies. Int J Pharm 2013; 458: 128-134.
22. Gullberg E, Leonard M, Karlsson J, Hopkins AM, Brayden D, Baird AW, Artursson P., Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun 2000; 279: 808-813.
23. Antunes F, Andrade F, Araujo F, Ferreira D, Sarmento B., Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 2013; 83: 427-435.
24. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A., Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 1990; 50: 6334-6343.
25. Sarmento B, Ribeiro A, Veiga F, Ferreira D., Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems. Biomed Chromatogr 2006; 20: 898-903.
26. Hidalgo IJ., Assessing the absorption of new pharmaceuticals. Curr Topic Med Chem 2001; 1: 385-401.
27. Sun H, Chow EC, Liu S, Du Y, Pang KS., The Caco-2 cell monolayer: Usefulness and limitations. Expert Opin Drug Metab Toxicol 2008; 4: 395-411.
28. Yu Q-H, Yang Q., Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier. Cell Biol Int 2009; 33: 78-82.
29. Farquhar MG, Palade GE., Junctional complexes in various epithelia. J Cell Biol 1963; 17: 375-412.
30. Wood KM, Stone GM, Peppas NA., The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater 2010; 6: 48-56.
31. Le Ferrec E, Chesne C, Artusson P, Brayden D, Fabre G, Gires P, Guillou F, Rousset M, Rubas W, Scarino ML., In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods. Altern Lab Anim 2001; 29: 649-668.
32. Legen I, Salobir M, Kerč J., Comparison of different intestinal epithelia as models for absorption enhancement studies. Int J Pharm 2005; 291: 183-188.
33. Daugherty AL, Mrsny RJ., Transcellular uptake mechanisms of the intestinal epithelial barrier part one. Pharm Sci Technol Today 1999; 2: 144-151.
34. Kavimandan NJ, Peppas NA., Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer. Int J Pharm 2008; 354: 143-148.
35. Tang C, Yu J, Yin L, Yin C, Pei Y., Transport of insulin in modified Valia-Chien chambers and Caco-2 cell monolayers. Drug Dev Ind Pharm 2007; 33: 449-456.
36. Bendayan M, Ziv E, Gingras D, Ben-Sasson R, Bar-On H, Kidron M., Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa. Diabetologia 1994; 37: 119-126.
37. Bendayan M, Ziv E, Ben-Sasson R, Bar-On H, Kidron M., Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium. Diabetologia 1990; 33: 197-204.
38. Ziv E, Bendayan M., Intestinal absorption of peptides through the enterocytes. Microsc Res Techniq 2000; 49: 346-352.
39. Pillion DJ, Ganapathy V, Leibach FH., Identification of insulin receptors on the mucosal surface of colon epithelial cells. J Biol Chem 1985; 260: 5244-5247.
40. Bai JF, Chang LL., Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium. Pharm Res 1995; 12: 1171-1175.
41. Chien YW., Human insulin: Basic sciences to therapeutic uses. Drug Dev Ind Pharm 1996; 22: 753-789.
42. Schimpel C, Teubl B, Absenger M, Meindl C, Fröhlich E, Leitinger G, Zimmer A, Roblegg E., Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm 2014; 11: 808-818.
43. Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y., Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 2012; 33: 1573-1582.
44. Shrestha N, Shahbazi MA, Araujo F, Zhang H, Makila EM, Kauppila J, Sarmento B, Salonen JJ, Hirvonen JT, Santos HA., Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers. Biomaterials 2014; 35: 7172-7179.